Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin, type II cuticular Hb1 (KRT81) is a type II (basic) hair keratin that is an essential intermediate filament protein found primarily in the cortex of hair shafts, where it confers strength and flexibility to the hair’s structure. It heterodimerizes with type I (acidic) keratins to form stable filaments that assemble into the cytoskeletal framework of hair and some other hard keratinized structures such as nails. Mutations in KRT81 are implicated in monilethrix, a rare autosomal dominant disorder characterized by fragile, beaded hair. While primarily expressed in hair follicles, KRT81 has been detected in certain breast cancer cells and metastatic lymph nodes, where its role remains unclear and is a subject of ongoing research, but it is not an established drug target and there are no known interacting drugs. KRT81 does not act as a receptor, enzyme, transporter, or conventional therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin, type II cuticular Hb1 (KRT81).